scispace - formally typeset
W

Wei Jiang Goh

Researcher at National University of Singapore

Publications -  17
Citations -  488

Wei Jiang Goh is an academic researcher from National University of Singapore. The author has contributed to research in topics: Medicine & Surface modification. The author has an hindex of 7, co-authored 15 publications receiving 340 citations. Previous affiliations of Wei Jiang Goh include Centre for Life & Singapore General Hospital.

Papers
More filters
Journal ArticleDOI

Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative.

TL;DR: The first demonstration of a simple and rapid production method of CDNs using spin cups via a cell shearing approach is shown, which offers clear advantages in terms of yield and cost-effectiveness over both traditional exosomes isolation, and also existing CDNs fabrication techniques.
Journal ArticleDOI

Iron Oxide Filled Magnetic Carbon Nanotube–Enzyme Conjugates for Recycling of Amyloglucosidase: Toward Useful Applications in Biofuel Production Process

TL;DR: These results, combined with the unique intrinsic properties of the nanotubes, pave the way for greater efficiency in carbon nanotube-enzyme bioreactors and reduced capital costs in industrial enzyme systems.
Journal ArticleDOI

Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy

TL;DR: It is proved that the addition of doxorubicin-loaded CDNs to the HeLa and HEK293 co-cultures showed a clear discrimination toward cancer cells at the cellular level, reinforcing the intriguing potential of CDNs as an alternative targeted strategy for anticancer therapy.
Journal ArticleDOI

A simple method of microneedle array fabrication for transdermal drug delivery

TL;DR: It is demonstrated that the microneedle arrays can be fabricated through a simple single-step process and needles were mechanically strong to penetrate skin, increasing the permeability of encapsulated drug through skin.
Journal ArticleDOI

EXOPLEXs: Chimeric Drug Delivery Platform from the Fusion of Cell-Derived Nanovesicles and Liposomes.

TL;DR: The preservation of cell membranes from precursor cells similarly to CDNs are reported, as well as high loading efficiencies of more than 65% with doxorubicin hydrochloride, a model chemotherapeutic drug, which illustrates the potential of EXOPLEXs as a novel DDS for targeted delivery of Chemotherapeutics.